SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TOSHI

TOSHI is currently seeing a surge in community conversation, fueled by recent exchange listings and increased social media presence, hinting at potential future catalysts. Despite some market volatility and skeptical voices, many within the dedicated community highlight its growing utility on the Base network and strong ties to Coinbase, viewing current price levels as a significant accumulation opportunity for long-term growth.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics (CVKD) is trending due to recent announcements regarding its expanding pipeline of anticoagulant assets and strategic collaborations for its lead candidate, tecarfarin. The community is actively discussing the company's shift from a single-asset focus and its potential to address unmet needs in cardiovascular care, with some highlighting its low float as a catalyst for significant price movements. However, a segment of investors expresses strong concerns over perceived dilutive financing practices and the nature of promotional activity surrounding the stock.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is drawing attention amid discussions around its "Quantum proof update" and perceived decoupling from broader market movements. The community is actively highlighting BCH's resilience, anticipating a major breakout and significant price appreciation, with some comparing its current setup to recent successful altcoin runs.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is experiencing a parabolic rally driven by concerns over physical silver shortages and China's impending export restrictions, sparking a heated debate among investors. Many anticipate sustained upside due to accelerating industrial demand and de-dollarization trends, while others caution that the market is overbought and due for a sharp correction, drawing parallels to previous speculative peaks. The current sentiment highlights extreme bullish conviction clashing with warnings of an imminent downturn.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is trending amid an unusually severe flu season and emerging bird flu concerns, highlighting its self-amplifying mRNA platform with promising early data for both seasonal and pandemic influenza vaccines. While some investors see a compelling long-term opportunity, community discussion is intensely divided following mixed interim results for its cystic fibrosis therapy, leading to a significant stock pullback that many believe is an overreaction given encouraging biological activity and ongoing institutional accumulation.

British American Tobacco plc is a holding company, which engages in the manufacture and distribution of tobacco products. Its brands include Kent, Dunhill, Lucky Strike, and Pall Mall. It operates through the following geographical segments: United States, Asia-Pacific and Middle East (APME), Americas and Sub-Saharan Africa (AMSSA), and Europe and North Africa (ENA). The APME geographical segment consists of markets in the Middle East merged with Asia-Pacific. The AMSSA geographical segment is composed of markets in East and Central Africa, West Africa, and Southern Africa merged with the Americas region. The ENA geographical segment includes markets in Russia, Ukraine, Caucasus, Central Asia, Belarus, Turkey, and North Africa merged with the Western Europe region. The company was founded by James Buchanan Duke on September 29, 1902 and is headquartered in London, the United Kingdom.

British American Tobacco Plc - ADR

British American Tobacco plc

British American Tobacco is actively discussed for its appealing high dividend yield and its perceived stability as a defensive investment. Traders and long-term holders are noting its accelerating growth in next-generation nicotine products and consistent share buybacks. Despite recent volatility stemming from ex-dividend actions and the Canadian lawsuit settlement, the community remains optimistic about BTI's strategic pivot towards reduced-risk alternatives.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is currently experiencing intense debate following its Ethereum staking initiatives and an upcoming shareholder vote on a substantial increase in authorized shares. Investors are sharply divided, with bulls highlighting significant potential revenue from staked ETH and institutional accumulation, while bears voice strong concerns over potential dilution and management's capital allocation strategy.

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.

FibroGen Inc

FibroGen is trending as its roxadustat drug secured FDA Orphan Drug Designation for myelodysplastic syndromes, alongside a positive FDA agreement on Phase 3 trial design for this new indication. This news, coupled with the completed sale of its China unit, which significantly boosted its cash reserves and extended its operational runway, is fueling optimism within the investment community. Many are now focused on the company's execution of upcoming clinical milestones and discussing the stock's potential revaluation given its strengthened financial position and pipeline developments.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is a focal point of market discussion, driven by critical progress across its gene therapy pipeline, including a recent strategic partnership bolstering its cash position and a highly anticipated regulatory decision for its Hunter Syndrome treatment. Community sentiment is also notably engaged with the potential of its Duchenne gene therapy, which is garnering attention for its differentiated profile compared to existing therapies in the sector. Many observers see the company as deeply undervalued given its multiple significant programs nearing commercialization.

Sprott Physical Silver Trust - Units

Sprott Physical Silver Trust ET

Sprott Physical Silver Trust (PSLV) is trending amidst intense community speculation about a significant silver short squeeze, driven by its recent inclusion on the U.S. critical minerals list and reports of increasing industrial demand. Investors are actively discussing unprecedented supply deficits, rising lease rates, and alleged long-term market manipulation breaking, with many favoring PSLV for its physical backing over other silver investment vehicles.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


jun8808guru

Jun-88